Article info

Download PDFPDF

Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study

Authors

  • Jean-David Zeitoun Centre d’Épidémiologie Clinique, Hôpital Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France Department of Gastroenterology and Nutrition, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France Department of Proctology, Groupe Hospitalier Diaconesses-Croix Saint-Simon, Paris, France PubMed articlesGoogle scholar articles
  • Joseph S Ross Department of Internal Medicine, Robert Wood Johnson Foundation Clinical Scholars Program, Yale School of Medicine, New Haven, Connecticut, USA Department of Internal Medicine, Section of General Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut, USA PubMed articlesGoogle scholar articles
  • Ignacio Atal Centre d’Épidémiologie Clinique, Hôpital Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France INSERM UMR 1153, Centre de Recherche Épidémiologie et Statistique Paris Sorbonne Cité (CRESS), METHODS Team, Paris, France PubMed articlesGoogle scholar articles
  • Alexandre Vivot Centre d’Épidémiologie Clinique, Hôpital Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France INSERM UMR 1153, Centre de Recherche Épidémiologie et Statistique Paris Sorbonne Cité (CRESS), METHODS Team, Paris, France PubMed articlesGoogle scholar articles
  • Nicholas S Downing Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Gabriel Baron Centre d’Épidémiologie Clinique, Hôpital Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France INSERM UMR 1153, Centre de Recherche Épidémiologie et Statistique Paris Sorbonne Cité (CRESS), METHODS Team, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France PubMed articlesGoogle scholar articles
  • Philippe Ravaud Centre d’Épidémiologie Clinique, Hôpital Hôtel Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France INSERM UMR 1153, Centre de Recherche Épidémiologie et Statistique Paris Sorbonne Cité (CRESS), METHODS Team, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France Department of Epidemiology, Columbia University Mailman School of Public Health, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jean-David Zeitoun; jdzeitoun{at}yahoo.fr
View Full Text

Citation

Zeitoun J, Ross JS, Atal I, et al
Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study

Publication history

  • Received July 12, 2017
  • Revised November 3, 2017
  • Accepted November 9, 2017
  • First published December 21, 2017.
Online issue publication 
December 21, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.